Literature DB >> 20092849

Photoselective prostatic vaporization for bladder outlet obstruction: 12-month evaluation of storage and voiding symptoms.

Cosimo De Nunzio1, Roberto Miano, Alberto Trucchi, Lucio Miano, Giorgio Franco, Stefano Squillacciotti, Andrea Tubaro.   

Abstract

PURPOSE: We evaluated voiding and storage symptom evolution in patients treated with prostate photoselective vaporization by a KTP laser.
MATERIALS AND METHODS: Enrolled in the study were 150 consecutive patients with lower urinary tract symptoms due to benign prostatic hyperplasia and a diagnosis of bladder outlet obstruction. Patients underwent prostate photoselective vaporization with the 80 W KTP laser. Baseline parameters included prostate volume, International Prostate Symptom Score with voiding and storage symptom subscores, uroflowmetry, pressure flow study and serum prostate specific antigen. Patients were followed 1, 3, 6 and 12 months after surgery.
RESULTS: Mean +/- SD patient age was 69.6 +/- 10 years. Mean prostate volume was 52 +/- 18 ml. Mean International Prostate Symptom Score was 22.3 +/- 4, mean maximum urine flow was 9 +/- 2.9 ml per second and mean Schäfer obstruction class was 3.6 +/- 1. An average of 190 +/- 44 kJ were delivered in a mean of 68 +/- 24 minutes with an average of 3.6 kJ/ml prostate. The mean number of fibers was 1.2 +/- 0.4. Mean catheterization time was 20 +/- 8 hours. Retrograde ejaculation was reported in 67% of patients. Prostate specific antigen was significantly decreased at 12 months (2.6 +/- 2.3 vs 0.9 +/- 0.7 ng/ml, p = 0.001). Storage symptoms decreased by 54.5%, 63.6%, 72.7% and 81.8% at 1, 3, 6 and 12 months, respectively (p <0.001). Voiding symptoms decreased 63.6%, 72.7%, 81.8% and 90.9% at 1, 3, 6 and 12 months, respectively (p <0.001).
CONCLUSIONS: As shown by a prostate specific antigen significant decrease, proper prostate debulking may be achieved by prostate photoselective vaporization. Significant continuous improvement in storage and voiding symptoms was observed at up to 12-month followup. 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20092849     DOI: 10.1016/j.juro.2009.11.050

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Outcome analysis of transurethral resection versus potassium titanyl phosphate-photo selective vaporization of the prostate for the treatment of benign prostatic hyperplasia; a randomized controlled trial with 4 years follow up.

Authors:  Bimalesh Purkait; Rahul Janak Sinha; Krishna Swamy A Srinivas; Ankur Bansal; Ashok Kumar Sokhal; Vishwajeet Singh
Journal:  Turk J Urol       Date:  2017-04-18

Review 2.  The relationship between photoselective vaporization of the prostate and sexual function.

Authors:  Franck Bruyère
Journal:  Curr Urol Rep       Date:  2011-08       Impact factor: 3.092

Review 3.  Comparison of Patients Undergoing PVP Versus TURP for LUTS/BPH.

Authors:  Blake B Anderson; Joseph J Pariser; Brian T Helfand
Journal:  Curr Urol Rep       Date:  2015-08       Impact factor: 3.092

4.  GreenLight HPS 120-W laser photoselective vaporization of the prostate as early therapy for acute urinary retention in advanced prostate cancer patients.

Authors:  Dong Chen; Boxin Xue; Yuxi Shan; Dongrong Yang; Chuanyang Sun; Jie Gao
Journal:  Lasers Med Sci       Date:  2013-01-03       Impact factor: 3.161

5.  A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual men.

Authors:  Raouf Seyam
Journal:  Ther Adv Urol       Date:  2013-10

Review 6.  Contemporary review of the 532 nm laser for treatment of benign prostatic hyperplasia.

Authors:  Bilal Chughtai; Leanna Laor; Claire Dunphy; Alexis Te
Journal:  Asian J Urol       Date:  2015-04-16

7.  Meta-analysis with individual data of functional outcomes following Aquablation for lower urinary tract symptoms due to BPH in various prostate anatomies.

Authors:  Dean Elterman; Peter Gilling; Claus Roehrborn; Neil Barber; Vincent Misrai; Kevin C Zorn; Naeem Bhojani; Alexis Te; Mitch Humphreys; Steven Kaplan; Mihir Desai; Thorsten Bach
Journal:  BMJ Surg Interv Health Technol       Date:  2021-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.